Barbara P. S.
- Country
- Poland
- Department
- Oddział Kliniczny Dzieci Starszych z Pododdziałem Neurologicznym, Reumatologicznym
Research Overview
- Phase 3 Randomized Double-Blind Placebo-Controlled Trial Evaluating Rimegepant Efficacy and Safety in Acute Migraine Treatment in Pediatric Patients Aged 6-17 Years
- Phase 3 Multicenter Open-Label Study on Long-Term Safety and Tolerability of Rimegepant for Acute Migraine Treatment in Pediatric Patients Aged 6 to 17 Years
- Evaluation of Safety and Efficacy of Cenobamate in Pediatric Patients with Partial-Onset Seizures: An Open-Label Clinical Trial
Data & Insights
Has run more than one trial at 38 of 125 partner sites.
Specializations
Pediatric Neurology
The investigator specializes in treating neurological conditions in children and adolescents, with particular emphasis on pediatric migraine management and preventive treatment approaches.
- Acute migraine treatment in children
- Migraine prevention strategies
- Age-specific therapeutic interventions (6-18 years)
Their work encompasses both acute and preventive treatment modalities for pediatric migraine patients.
Movement Disorders
The investigator focuses on neurological movement disorders, particularly Tourette's Disorder in pediatric and adolescent populations.
- Tourette's Disorder management
- Tic severity assessment
- Novel therapeutic approaches
Their expertise extends to evaluating innovative treatments for movement disorders in young patients.
Epilepsy Treatment
The investigator demonstrates expertise in treating partial-onset seizures in pediatric patients, focusing on developing therapeutic interventions for focal epilepsy.
- Pediatric seizure management
- Focal epilepsy treatment
- Safety evaluation in young patients
Their research includes evaluating treatments for children with focal seizures between ages 2 and 18.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.